Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DISPLAY ELEMENT BASED ON THE ELECTROCLINIC EFFECT
Document Type and Number:
WIPO Patent Application WO/1989/011451
Kind Code:
A1
Abstract:
The invention relates to a display element based on the electroclinic effect containing a liquid crystal medium being a mixture of at least two chiral components and at least one non-chiral component, characterised in that said medium has a pitch compensated cholesteric phase above the optically active smectic A phase.

Inventors:
COATES DAVID (GB)
SAGE IAN CHARLES (GB)
GEELHAAR THOMAS (DE)
WAECHTLER ANDREAS (DE)
Application Number:
PCT/EP1989/000518
Publication Date:
November 30, 1989
Filing Date:
May 12, 1989
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MERCK PATENT GMBH (DE)
International Classes:
C09K19/42; G02F1/13; C09K19/46; G02F1/1337; G02F1/137; G02F1/139; (IPC1-7): C09K19/42
Foreign References:
EP0201341A21986-11-12
Other References:
See also references of EP 0391986A1
Download PDF:
Claims:
Claims
1. Display element based on the electroclinic effect containing a liquid crystal medium being a mixture of at least two chiral components and at least one nonchiral component, characterised in that said medium has a pitch compensated cholesteric phase above the optically active smectic A phase.
2. Display element according to Claim 1 characterised in that at least one nonchiral component is a compound of the formula I R1 ø n COO 0 pn R (I) wherein R1 a ind R2 aarree eeach independently an alkyl group with 5 to 15 C atoms wherein one or two nonadjacent CH2 groups can also be replaced by O, S, CO0, OCO and /or CH=CH, A \ denotes a 1,4phenylene group option¬ ally substituted by fluorine and n and m are each independently 1 or 2, and at least one chiral component is a compound of the formula II R 3(A1Z1X) A2QCH*R4* (ID I Y wherein R 3 is an alkyl or alkenyl group each with 5 to 15 C atoms, optionally substituted by CN or at least one halogen atom wherein one or two nonadjacent CH_ groups can be replaced by 0, CO, CO0, OCO, S and/or C≡C, R is an alkyl group with up to 8 C atoms wherein one CH2 group can be replaced by O, COO or OCO, A 1 and A2 independently are an unsubstituted or mono or polysubstituted 1,4cyclohexylene group, wherein one or two nonadjacent CH2 groups may be replaced by O and/or S, or denote a l,4bicyclo[2,2,2]octylene group, or a 1, phenylene group optionally substituted by fluorine, and wherein one or two CH groups may be replaced" by N, is CN, Cl, F, Br, CH or CF3' denotes CO0, OCO, CH2CH2, CHCNCH2, CH2CHCN, CH=CH, C≡C, OCH2>, CH20, CH=N, N=CH, N=N, NO=N, N=NO or a single bond, is 1, 2, or 3, and is an alkylen or alkenylen group with 1 to 7 C atoms wherein one CH? group can be replaced by O, COO or OCO, with the proviso that X, Y and R 4 bexng dxfferent groups.
3. Display element according to Claim 1, characterised in that at least one component is a compound of the formula III wherein R and R are each independent an alkyl group with 5 to 15 C atoms wherein one or two CH2 groups can also be replaced by 0, S COO, OCO and/or CH=CH B \ denotes a 1,.
4. phenylene group optionally — substituted by fluorine, 0( C ) denotes a 1,4phenylene group optionally substituted by fluorine or a trans1,4 cyclohexylene group, q is 0 or 1, and r is 1, or 2, and at least one chiral component is a compound of the ffoorrmmuullaa IIII wwhheerreeiirn R 3, R4, A1, A , Y and Q have the meaning given.
5. 4 Display element according to Claim 2, characterised in that in formula I at least one group AV denotes a 1,4phenylene group wich is substitued by fluorine.
6. Display element according to the Claims 2 or 4, characterised m that R 1 and R2 in formula I are each alkyl or alkoxy with 5 to 15 C atoms.
7. Display element according to the Claim 3, charac 5 c terised in that R and R in formula III are each alkyl or alkoxy with 5 to 15 C atoms.
Description:
Display Element based on the Electroclinic Effect

The invention relates to a display element based on the electroclinic effect containing a liquid crystal medium being a mixture of at least two chiral components and at least one non-chiral component, characterised in that said medium has a pitch compensated cholesteric phase above the optically active smectic A phase.

Ferroelectric smectics have recently entered the domain of liquid-crystal application in the so-called SSFLC (sur¬ f ce stabilized ferroelectric liquid crystal) device des¬ cribed by Clark and Lagerwall (N.A. Clark and S.T. Lager- wall, Appl. Phys. Lett. 3j5, 899 (1980); U.S. Patent Speci¬ fication 4,367,924).

This device utilizes the chiral smectic C phase or any chiral tilted smectic phase each of which has the charac¬ teristic of being ferroelectric.

The existence of a spontaneous polarization is possible only in chiral tilted smectic phases. However, in non- tilted smectic phases, like smectic A, built up from chi¬ ral molecules one observes an induced tilt on applying an external electric filed. Garoff and Meyer (S. Garoff and R.B. Meyer, Physical Review Letters 38_, 848 (1977); Physical Review A 19, 338 (1979)) first described this so-called electroclinic effect (ECE).

The device they used shows only a small ECE and requires phase-sensitive methods for its detection.

Anderson et al. (G. Anderson et al., Appl. Phys. Lett. 51, 640 (1987); European Patent Application 0 263 225) des- cribe a device having a geometry in which the samples are very thin and the smectic layers are perpendicular (in¬ stead of parallel) to the glass plates (this is the so- called bookshelf geometry typical of the SFLC-cells). In this device the ECE is detectable at conveniently low applied fields. This leads to an ECE which is also linear and gives a very fast response for a given sub¬ stance.

Different compounds showing an ECE are investigated by Nishiyama et al. (Jap. J. of Appl. Phys. 6_, 1787 (1987)) or by Ch. βahr and G. Heppke (Liquid Crystals, 1987, 825).

A great disadvantage for applications based on the elec¬ troclinic effect of the compounds currently available with smectic A phases is their low chemical, heat and light stability. Another adverse property of displays based on the ECE with compounds currently available is that they are difficult to align to an extent which is sufficient for practical application. But for many applications good alignment is vital although a smectic A phase does align over rubbed polymer (e.g. Patel, J.S., Leslie, T.M. and Goodby, J.W., Ferroelectrics 1984, 59, 137) and SiO, this process is much easier if a nematic phase precedes the smectic A phase.

The high cost of the chiral compounds used as single components in these displays is another disadvantage of the displays based on the ECE whic h are described until today.

Moreover, the temperature range of the smectic A phases showing an ECE is usually too small and is predominantly at temperatures being too high for commercial applications.

It now has been found that a display element based on the ECE with a liquid crystal medium which contains at least two chiral components and at least one non-chiral compo¬ nent and has a pitch compensated cholesteric phase above the optically active smectic A phase can substantially reduce the disadvantages mentioned.

Such a display element can particularly be used over a wide temperature range. The phases therein possess a high Ps value and a compensated cholesteric phase which leads to a good alignment and a high induced tilt angle.

Ps is the spontaneous polarization in nC/cm 2 . Furthermore the costs of such a display containing a mixture of chi- ral and non-chiral compounds is essentially lower than those of one containing only chiral compounds.

The invention thus relates to a display element based on the electroclinic effect containing a liquid crystal medium being a mixture of at least two chiral compo- nents and at least one non-chiral component, character¬ ised in that said medium has a pitch compensated cholesteric phase above the optically active smectic A phase.

The invention furthermore relates to such a display element characterised in that at least one non-chiral component is a compound of the formula I

R 1 - 0- " n -CO-0- (I)

wherein

R X and R 2 are with 5 to 15 C atoms wherein one or two non-adjacent CH ? groups can also be replaced by -0-, -S-, -CO-0-, -O-CO- and /or -CH=CH-,

-©- denotes a 1,4-phenylene group option¬ ally substituted by fluorine and

n and m are each independently 1 or 2, and

at least one chiral component is a compound of the formula II

R 3 -(A 1 -Z 1 ) -A 2 -Q-CH*-R 4 (ii)

I y

wherein

3 R is an alkyl or alkenyl group each with

5 to 15 C atoms, optionally substituted by CN or at least one halogen atom wherein one or two non-adjacent CH 2 groups can be replaced by -0-, -CO-, -CO-0-, -0-CO-,

-S- and/or -C≡C-,

R 4 is an alkyl group with up to 8 C atoms wherein one CH 2 group can be replaced by

-0-, -CO-0- or -O-CO-,

A and A independently are an unsubstituted or mono- or polysubstituted 1,4-cyclohexylene group, wherein one or two non-adjacent CH 2 groups may be replaced by -O- and/or -S-, or denote a l,4-bicyclo[2,2,2]octylene group, or a 1,4-phenylene group optionally substituted by fluorine, and wherein one or two CH groups may be replaced by N,

X is CN, Cl, F, Br, CH 3 or CF 3 ,

Y is H or CH 3 ,

Z 1 denotes -CO-0-, -0-CO-, -CH 2 CH 2 -, -CHCN-CH 2 -,

-CH 2 -CHCN-, -CH=CH-, -C≡C-, -OCH 2 ~, -CH 2 0, -CH=N-, -N=CH-, -N=N-, -NO=N-, -N=NO- or a single bond,

o is 1, 2, or 3, and

Q is an alkylen or alkenylen group with 1 to 7 7 CC aattoommss wwhheerreeiinn oonnee CCHH„„ group can be replaced by -0-, -CO-O- or -O-CO-, wwiitthh tthhee pproviso that X, Y and R 4 being differ- ent groups

The invention relates furthermore to such a display ele¬ ment, characterised in that at least one component is a compound of the formula III

R - -© — - a-GN- -0— -r* 6 (III)

wherein

R 5 and R6 are each independent an alkyl group with

5 to 15 C atoms wherein one or two CH- groups can also be-replaced by -0-, -S-

-CO-0-, -O-CO- and/or -CH=CH-

-0 denotes a 1,4 phenylene group optionally substituted by fluorine,

0- denotes a 1,4-phenylene group optionally substituted by fluorine or a trans-1,4- cyclohexylene group,

is 0 or 1, and

is 1 or 2,

and

at least one chiral component is a compound of the ffoorrmmuullaa IIII wwhheerreeiirn R 3, R4, A1, A2, Y and Q have the meaning given.

In particular the invention relates to such a display element, characterised in that in formula I at least one group — AV- denotes a 1,4-phenylene group wich is substitued by fluorine, and to such a display element, characterised in that R 1 and R2 i.n formula I are each alkyl or alkoxy with 5 to 15 C atoms.

Furthermore the invention relates to such a display ele- ir c ment, characterised in that R and R in formula III are each alkyl or alkoxy with 5 to 15 C atoms.

Preferred display elements according to the invention are those in which the non-chiral base mixture comprises compounds of the formula I.

Particularly preferred compounds of the formula I are those of the part formulae la to Ik:

Particularly preferred display elements according to the invention are those in which the non-chiral base mixture comprises compounds of the formula III. Preferred com¬ pounds of the formula III are those of the part formu¬ lae Ilia to Illi:

I He

RS -0 ~ < 2 -®- SC Hid

"-Q ^ " ® " "' Hie

Particularly preferred display elements according to the invention are those in which the both chiral components are of the formula II. Preferred compounds of the for¬ mula II are those of the part formulae I la to Ilf:

R 7 -^ 1 -^O^-CO-O-CHCN-R 8 Ha

R 7 -^ 1 o _0_ 0 -(CH 2 ) s -CHCH 3 -R 8 lib

R 7 -(A 1 o -^θ -0-CO-CHCl-R 8 He

R 7 - ( A 1 o - -(CH 2 ) s -O-CHCH 3 -CO 2 -R 8 lid

R 7 -(A 1 0 -(θ)- ( CH 2 ) s -0-CO-CHCH 3 -O-R 8 He

R 7 -(A ] Q -(O - ( CH 2 ) s -CO-0-CHCH 3 -C0 2 -R Ilf

wherein R7 is alkyl or alkoxy with 5 to 15 C atoms, R8 is alkyl with 1 to 8 C atoms, 0 is 1 or 2, s is 0 or an. integer value between 1 and 6 and A is preferably

1,4-phenylene, pyridine-2,5-diyl pyrimidine-2,5-diyl, 2-fluoro-l,4-phenylene or trans-1, -cyclohexylene. R and R 2 (in the compounds of the formula I) and R5 and

R (in the compounds of the formula III) independently of one another are each preferably alkyl, alkoxy, alkanoyl, alkanoyloxy, alkoxycarbonyl or alkoxycarbonyloxy, each preferably having 5 to 12, in particular 6 to 10, C atoms. Alkyl and alkoxy are particularly preferred. A particu¬ larly preferred combination in the compounds of the for- mula I xs one in wich R 1 is alkoxy and R2 is alkyl. A particularly preferred combination in the compounds of the formula III is one in which R is alkyl and R is alkoxyT R 1 and R2 groups with a straight-chain alkyl radi¬ cal are particularly preferred.

Particularly preferred display elements according to the invention are those in which the achiral base mixture contains, in addition to compounds of the formula I or III, at least one other component with a negative or comparatively low positive dielectric anisotropy. This/ these other component(s) of the achiral base mixture can make up 1 to 95 %, preferably 5 to 40 %, of the base mixture. Suitable further components with a comparatively low positive or negative dielectric anisotropy are com¬ pounds of the formulae IV to VII.

CN

R 9 -(A 3 ) u -( (A | v -E 10 VII

wherein R 9 and R10 are each alkyl or alkoxy with 5 or 15 C atoms, L is hydrogen or fluorine, A 3 and A4 each independently are 1,4-phenylene or trans-l,4-cyclohexy- lene, u and v are each independently 0, 1 or 2, the sum of u + v is 1 or 2 and t is 1 or 2.

All components of the phases according to the invention are either known or can be prepared in a manner known per se, analogously to known compounds.

Esters of the formula I can be obtained by esterifica- tion of corresponding carboxylic acids (or their reac¬ tive derivatives) with phenols (or their reactive derivatives).

The corresponding carboxylic acids and phenols are known or can be prepared by processes analogous to known processes.

Particularly suitable reactive derivatives of the carboxylic acis mentioned are the acid halides, above all the chlorides and bromides, and furthermore the an¬ hydrides, for example also mixed anhydrides, azides or esters, in particular alkyl esters with 1-4 C atoms in the alkyl group.

Possible reactive derivatives of the alcohols or phenols mentioned are, in particular, the corresponding metal phenolates, preferably of an alkali metal, such as sodium or potassium.

The esterification is advantageously carried out in the presence of an inert solvent. Particularly suitable solvents are esters, such as diethyl ether, di-n-butyl ether, THF, dioxane or anisole, ketones, such as acetone, butanone or cyclohexanone, amides, such as dimethylform- amide or phosphoric acid hexamethyltriamide, hydrocar¬ bons, such as benzene, toluene or xylene, halogenohydro- carbons, such as dichloromethane carbon tetrachloride or tetrachloroethylene, and sulfoxides, such as dimethyl- sulfoxide or sulfolane. Water-immiscible solvents can simultaneously be advantageously used for azeotropic distillation of the water formed during the esterifica¬ tion. An excess of an organic base, for example pyridine, uinoline or triethylamine, can occasionally also be used as the solvent for the esterification. The esterifica¬ tion can also be carried out in the absence of "a solvent, for example by heating the components in the presence of sodium acetate. The reaction temperature is usually between -50° and +250°, preferably between -20° and +80°. At these temperatures, the esterification reac¬ tions have as a rule ended after 15 minutes to 48 hours.

In detail, the reaction conditions for the esterification depend largely on the nature of the starting substances used. Thus, a free carboxylic acid is as a rule reacted with a free alcohol or phenol in the presence of a strong acid, for example a mineral acid, such as hydrochloric acid or sulfuric acid. A preferred reaction procedure is the reaction of an acid anhydride or, in particular, an acid chloride with an alcohol, preferably in a basic medium, bases which are of importance being, in parti- cular, alkali metal hydroxides, such as sodium hydroxide or potassium hydroxide, alkali metal carbonates or bi- carbonates, such as sodium carbonate, sodium bicarbonate, potassium carbonate or potassium bicarbonate, alkali metal acetates, such as sodium acetate or potassium acetate, alkaline earth metal hydroxides, such as calcium hydroxide, or organic bases, such as triethyl- amine, pyridine, lutidine, collidine or quinoline. Another preferred embodiment of the esterification comprises first converting the alcohol or phenol into the sodium alcoho- late or phenolate or potassium alcoholate or phenolate, for example by treatment with ethanolic sodium hydroxide solution or potassium hydroxide solution, isolating this product and suspending it in acetone or diethyl ether, together with sodium bicarbonate or potassium carbonate, with stirring, and adding a solution of the acid chloride or anhydride in diethyl ether, acetone or dimethylform- amide to this suspension, advantageously at temperatures between about -25° and +20°.

A further preferred reaction procedure is the reaction of an acid with an alcohol in an inert solvent in the presence of a water binding material, e.g. molecular sieves or carbodiimides, preferably dicyclohexylcarbo- diimide (DCC).

The phases according to the invention are prepared in a manner which is customary, for example by mixing the components together, preferably at elevated temperatures,

The liquid crystal phases according to the invention can be modified by suitable additives so that they can be used, in all the types of liquid crystal display elements hitherto disclosed.

The geometry of the display according to the invention is, for example, that described by Anderson et al. (Appl. Phys. Lett. 51, 640 (1987); European Patent Application 0 263 225).

The following examples are intended to illustrate the invention without limiting it. Percentages above and below are percentages by weight; all the tempera- tures are stated in degrees Celsius. The values given for spontaneous polarization are applicable to room temperature. The symbols are furthermore as follows: Cr: crystalline solid state, S: smectic phase (the index characterizes the phase type), N: nematic state, Ch: cholesteric phase, I: isotropic phase. The figure between two symbols indicates the transition temperature in degrees Celsius.

Example 1

A liquid crystal medium consisting of

20.3 % of 4-pentyl-2-fluorophenyl 4'-octyloxybiphenyl- 4-ylcarboxylate 20.3 % of 4-heptyl-2-fluorophenyl 4'-heptyloxybiphenyl- 4-ylcarboxylate

20.3 % of 4-heptyl-2-fluorophenyl 4'-octyloxy-3 '-fluoro- biphenyl-4-ylcarboxylate 16 % of 4-pentyl-2-fluorophenyl 4'-octyloxybenzoate 16 % of optically active l-cyano-3-methylpropyl 4'-octyl- oxy-3'-fluorobiphenyl-4-ylcarboxylate and

7 % of optically active 1-cyanoethyl 4'-octyloxy-3'- fluorobiphenyl-4-ylcarboxylate

exhibits S* 28° S A 73° Ch 89-92° I, a significant field induced tilt angle in the smectic A phase and a helix compensated cholesteric phase. Due to this feature this medium can be readily aligned to produce a good alignment of the smectic A phase.

The following tables illustrate the effect of applying a dc field to this liquid crystal medium aligned with rubbed polya ide and contained in a 2,4 μ thick cell.

TILT ANGLE vs TEMPERATURE at 20 v/μm

Temperature (°C) Tilt Angle (°)

29 14 30 13 33 11.5 38 9 40 7 43 6 48 5.5 53 5

TILT ANGLE (°) vs APPLIED FIELD at Various Temperatures

Field (v/μm) Temperature (°C)

29 31 33 38 46

5 8 7 6.5 3 1.5

10 10.5 9 8.5 5 2.5

15 12 11 10 6.5 4

20 14 12.5 11.5 9 5

25 13 12 10.5 10 6

Example 2

A liquid crystal medium consisting of

3.9 % of 2-p-hexyloxyphenyl-5-heptylpyrimidine

3.9 % of 2-p-heptyloxyphenyl-5-hep ylpyrimidine

3.9 % of 2-p-octyloxyphenyl-5-heptylpyrimidine 3.9 % of 2-p-nonyloxyphenyl-5-heptylpyrimidine

24.0 % of 2-p-heptyloxyphenyl-5-hexylpyrimidine

2.0 % of 2-p-hexyloxyphenyl-5-nonylpyrimidine 26.0 % of 2-p-nonyloxyphenyl-5-nonylpyrimidine 9.8 % of r-l-cyano-cis-4-(trans-4-pentylcyclo- hexyl)-1-(trans-4-pentylcyclohexyl)-cyclohexane

2.6 % of optically active 2-(4-(3,7-dimethyloctyloxy)- phenyl)-5-nonylpyrmidine and 20 % of optically active 4-(5-heptylpyrimidine-2-yl)- phenyl 2-chloro-4-methylbutyrat

exhibits C -20° S Ά. 62° Ch 66° I and a cholesteric pitch of -14 μm at 63 °C.

Example 3

A liquid crystal medium consisting of

17 % of 4-pentyl-2-fluorophenyl 4'-octyloxybiphenyl-4-yl- carboxylate 17 % of 4-heptyl-2-fluorophenyl 4 f -heptyloxybiphenyl-4-yl- carboxylate 17 % of 4-heptyl-2-fluorophenyl 4'-octyloxy-3'-fluorobi- phenyl-4-yl carboxylate 16 % of 4-pentyl-2-fluorophenyl-4'-octyloxybenzoate 10 % of 4-pentylphenyl 4'-heptylbenzoate

16 % of optically active l-cyano-3-methylpropyl 4'-octyl- oxy-3'-fluorobiphenyl-4-yl carboxylate and 7 % of optically active 1-cyanoethyl 4'-octyloxy-3'-fluoro- biphenyl 4-yl carboxylate

exhibits S* -1.6° S. 60° Ch 75.7° I, a significant field induced tilt angle in the smectic A phase and a helix compensated cholesteric phase.

The following table illustrates the effect of applying a dc field to this liquid crystal medium:

Induced Tilt Angle at 20 °C

Field (V/μm) Induced Tilt (°)

5 2

10 4 15 6

20 8

25 9

Example 4

A liquid crystal medium consisting of

13.19 % of 4-n-octyloxy-2'-fluoro-4"-n-pentyl-p-terphenyl 13.23 % of 4-n-pentyloxy-2 , -fluoro-4"-(4-methylhexyl)- p-terphenyl

13.17 % of 4-n-heptyloxy-2 , -fluoro-4"-(4-methylhexyl)- p-terphenyl 15.47 % of 4-n-heptylphenyl 4*-pentylbenzoate 14.99 % of 4-octyloxy-3-fluorophenyl 4•-octyloxybenzoate 15.09 % of 4-pentyl-3-fluorophenyl 4•-octyloxybenzoate

4.98 % of optically active l-cyano-3-methylpropyl 4*-octyl- oxy-3'-fluoro biphenyl-4-yl carboxylate 9.86 % of optically active 1-cyanoethyl 4 ! -octyloxy-3'- fluoro biphenyl-4-yl-carboxylate

exhibits S* 23.6° S A 52.6° Ch 71.7 ° I.